Aim is to accelerate and streamline research through an innovative digital platform for knowledge sharing.

Malaria vaccine development.

The company is focused on the use of bacteriocins and anti-microbial therapies.

Glycosolation technology.

Mining large digital pathology datasets through a web platform that can manage a crowd sourced approach to annotation.

Developing international trade and transport simulators, using mathematical models and machine learning.

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

Behaviour-based analytics.

LED spin-out using Perovskite technology.

Custom made helmet using 3D printing.

To discover significantly de-risked novel drug targets for licensing and in-house development.

Cleaner, safer, faster chemical production.

Inkpath is a skills tracking app which helps it's users plan and track their career development in a smart format.

Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.

Controlling insects that spread disease.

Develop technologies that miniaturise fluid handling to accelerate drug discovery.

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Company developing a new gene therapy products for the treatment of rare diseases.

First commercial producer of sustainable, guilt-free meat.

A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.